NCT01694719

Brief Summary

The purpose of this study is to evaluate the potential effects of a cognitive training program when combined with a particular form of psychotherapy (behavioral activation therapy) for depression. Behavioral activation therapy targets changes in behavior as a method for improving a depressed individual's thoughts, feelings, and overall quality of life. This study is designed to test whether a computerized brain exercise called cognitive control training can enhance the effects of a 5-session behavioral activation therapy program. CCT has been shown to reduce depressive symptoms in two other studies, but it has not yet been combined with behavioral activation therapy. The investigators hypothesize that individuals assigned to the behavioral activation plus cognitive control training condition will demonstrate reduced depressive symptoms from pre to post treatment compared with those assigned to the behavioral activation plus computerized control condition. The investigators hypothesize that these gains will be maintained at one-month follow up.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
26

participants targeted

Target at below P25 for not_applicable depression

Timeline
Completed

Started Sep 2012

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2012

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

September 24, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 27, 2012

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
Last Updated

September 27, 2012

Status Verified

September 1, 2012

Enrollment Period

1.1 years

First QC Date

September 24, 2012

Last Update Submit

September 26, 2012

Conditions

Keywords

DepressionMajor Depressive DisorderBehavioral ActivationCognitive Training

Outcome Measures

Primary Outcomes (1)

  • Beck Depression Inventory

Secondary Outcomes (1)

  • Montgomery Asberg Depression Rating Scale

Other Outcomes (1)

  • Ruminative Response Scale

Study Arms (2)

Behavioral Activation + Cognitive Control Training

EXPERIMENTAL

Participants will receive 5 sessions of behavioral activation therapy concurrent with 4 sessions of cognitive control training, a computerized intervention which targets cognitive control processes such as working memory and attention.

Behavioral: Brief Behavioral Activation Treatment for DepressionBehavioral: Cognitive Control Training

Behavioral Activation Therapy plus Control Task

ACTIVE COMPARATOR

Participants will receive 5 sessions of behavioral activation therapy and 4 sessions of a non-active, computerized control task.

Behavioral: Brief Behavioral Activation Treatment for Depression

Interventions

Behavioral Activation + Cognitive Control TrainingBehavioral Activation Therapy plus Control Task
Behavioral Activation + Cognitive Control Training

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults ages 18-65
  • Primary psychiatric diagnosis of major depressive disorder
  • Ability to read and speak English sufficiently to complete study procedures
  • If taking antidepressant or anxiolytic medication, participants must be taking a stabilized dose for a minimum period of at least 8 weeks prior to entry into the study
  • Willingness and ability to comply with the requirements of the study protocol

You may not qualify if:

  • Lifetime history of bipolar disorder or psychotic disorder
  • Neurological disorder such as Parkinson's disease or traumatic brain injury
  • Alcohol or substance dependence within the past 6 months
  • Substantial suicide risk
  • Concurrent psychotherapy initiated within 2 months of baseline, or ongoing psychotherapy of any duration directed specifically toward treatment of the depression other than general supportive therapy
  • Current use of antipsychotics, stimulants, or modafinil

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston University - Translational Research Program

Boston, Massachusetts, 02215, United States

RECRUITING

MeSH Terms

Conditions

DepressionDepressive Disorder, Major

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorDepressive DisorderMood DisordersMental Disorders

Central Study Contacts

Samantha J Moshier, M.A.

CONTACT

Michael W Otto, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctoral Candidate in Psychology

Study Record Dates

First Submitted

September 24, 2012

First Posted

September 27, 2012

Study Start

September 1, 2012

Primary Completion

October 1, 2013

Study Completion

October 1, 2013

Last Updated

September 27, 2012

Record last verified: 2012-09

Locations